Mechanism of growth-inhibitory effect of cisplatin on human pancreatic cancer cells and status of p53 gene

Anticancer Research

Volumn 21, Issue 3 B, 2001, Pages 1919-1924

  Seki, T ^a   Ohba, N ^a   Makino, R ^a   Funatomi, H ^a   Mitamura, K ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; bcl 2 family; Cisplatin; p53; Pancreatic cancer

Indexed keywords

CISPLATIN; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; GENE MUTATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, WESTERN; CELL DIVISION; CISPLATIN; CULTURE MEDIA, SERUM-FREE; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, P53; HUMANS; MUTATION; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0034909622     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Current concepts in pancreatic cancer: Symposium summary
2. A multispeciality approach to the diagnosis and management of pancreatic cancer
3. Mechanistic analysis and chemo-prevention of pancreatic carcinogenesis
4. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode
5. Cellular responses to cisplatin
6. Cisplatin
7. Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma
8. A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer
9. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
10. K-ras and p53 mutations in pancreatic cancer: Ductal and nonductal tumors progress through different genetic lesions
11. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions
12. The bcl-2 protein family: Arbiters of cell survival
13. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin
14. The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells
15. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene
16. Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways
17. Bcl-2, bax and p53 expression in B-cell in relation to in vitro survival and clinical progression
18. Expression of bcl-x in erythroid precursors from patients with polycythemia vera
19. The dual role of mutant p53 protein in chemosensitivity of human cancers
20. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: Apoptosis vs. necrosis
21. Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death
22. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis
23. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
24. Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma
25. Regulation of CD95 (APO-1/FAS) ligand and receptor expression in squamous-cell carcinoma by interferon-γ and cisplatin